Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma

• Aibin Liu,
• Jinrong Zhu,
• Geyan Wu,
• Lixue Cao,
• Zhanyao Tan,
• Shuxia Zhang,
• Lili Jiang,
• Jueheng Wu,
• Mengfeng Li,
• Libing Song,
• Jun Li

Affiliations

Aibin Liu

Program of Cancer Research, Affiliated Guangzhou Women and Children’s Hospital, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University

Jinrong Zhu

Program of Cancer Research, Affiliated Guangzhou Women and Children’s Hospital, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University

Geyan Wu

Program of Cancer Research, Affiliated Guangzhou Women and Children’s Hospital, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University

Lixue Cao

Program of Cancer Research, Affiliated Guangzhou Women and Children’s Hospital, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University

Zhanyao Tan

Program of Cancer Research, Affiliated Guangzhou Women and Children’s Hospital, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University

Shuxia Zhang

Program of Cancer Research, Affiliated Guangzhou Women and Children’s Hospital, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University

Lili Jiang

Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Jueheng Wu

Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University

Mengfeng Li

Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University

Libing Song

State Key Laboratory of Oncology in Southern China, Department of Experimental Research, Cancer Center, Sun Yat-sen University

Jun Li

Program of Cancer Research, Affiliated Guangzhou Women and Children’s Hospital, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University